- Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
-
Juhasz A, Wu J, Hisada M, Tsukada T, Jeong MH
- KMID: 2434256
- Clin Hypertens.
- 2018 ;24(1):2.
- doi: 10.1186/s40885-018-0086-4
BACKGROUND: This was a phase 3, randomized, double-blind, placebo-controlled study. METHODS: Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were... -
- CITED
-
- Close
- SHARE
-
- Close
